title: Apolipoprotein E represents a potent gene-based therapeutic target for the treatment of sporadic Alzheimer's disease.
authors.affiliation: McGill Centre for Studies in Aging and Douglas Mental Health University Institute, Montreal, Quebec, Canada. judes.poirier@mcgill.ca
authors.forename: Judes
authors.initials: J
authors.lastname: Poirier
mesh_terms: D000544:Alzheimer Disease / Q000235:genetics*; D000818:Animals; D001057:Apolipoproteins E / Q000235:genetics*; D001921:Brain / Q000201:enzymology*; D002986:Clinical Trials as Topic; D020022:Genetic Predisposition to Disease; D015316:Genetic Therapy / Q000379:methods; D006801:Humans
chemical_list: D001057:Apolipoproteins E